A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.
A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.
T. Lobatón,A. López-García,3 Authors,J. Guardiola
2013 · DOI: 10.1016/j.crohns.2013.05.005
Journal of Crohn's & Colitis · 160 Citations
TLDR
Evaluating the ability of FC determined by a new quantitative point-of-care test (FC-QPOCT) to predict endoscopic remission and postoperative recurrence in CD patients found it correlated better with endoscopic activity in the ileocolonic location than the colonic location.